Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Molecular Medicine Today|May 14, 1999
Nucleoside transporters: molecular biology and implications for therapeutic developmentS A Baldwin, J R Mackey, C E Cass, et al.
Clinical Breast Cancer|March 20, 2002
Internet usage among women with breast cancer: an exploratory studyJ L Pereira, S Koski, J Hanson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2012
Targeting triple-negative breast cancer: optimising therapeutic outcomesK Gelmon, R Dent, J R Mackey, et al.
Current Oncology (Toronto, Ont.)|June 23, 2016
Real-world adjuvant TAC or FEC-D for HER2-negative node-positive breast cancer in women less than 50 years of ageS Lupichuk, D Tilley, X Kostaras, et al.
Current Oncology (Toronto, Ont.)|April 8, 2015
Systemic treatment approaches in her2-negative advanced breast cancer-guidance on the guidelinesA A Joy, M Ghosh, R Fernandes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 19, 2017
Beta blockers and improved progression-free survival in patients with advanced HER2 negative breast cancer: a retrospective analysis of the ROSE/TRIO-012 studyG Spera, R Fresco, H Fung, et al.
Current Oncology (Toronto, Ont.)|June 19, 2018
Hormone receptor-positive, HER2-negative metastatic breast cancer: redrawing the linesA Matutino, A A Joy, C Brezden-Masley, et al.
Pageof 7